InvestorsHub Logo
Followers 21
Posts 980
Boards Moderated 0
Alias Born 03/20/2019

Re: Webster_iam post# 351654

Sunday, 08/22/2021 12:22:23 AM

Sunday, August 22, 2021 12:22:23 AM

Post# of 429394
Very interesting. This is the agreement:
https://www.sec.gov/Archives/edgar/data/0000897448/000156459018003389/amrn-ex1068_470.htm

I have not been able to find what happens upon a change of control. I guess unless specifically spelled out typically the acquirer would assume the contract with HLS. Unless of course there is a provision that says this agreement terminates upon a change of control.

I guess you're saying that if Pfizer bought Amarin, even with the existing contract in place HLS would have more negotiating leverage with Pfizer in the event Pfizer wanted to alter the terms of their current arrangement?


Also as another poster pointed out it looks like Amarin had to give its consent for Pfizer to enter this agreement with HLS. See section 2.1.3. All very interesting. Amarin was definitely in the loop here.

2.1.3Licensee’s Right to Sublicense. Licensee shall have the right to sublicense those rights granted to it under Sections 2.1.1 and 2.1.2 to (a) Affiliates, subject to Licensee’s prior written notice to Amarin of the identity of such Affiliate and the purpose of such sublicense, and (b) Third Parties, subject to first obtaining Amarin’s prior written consent (such consent not to be unreasonably withheld, conditioned or delayed) (each of (a) and (b), a “Sublicensee”); [***]
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News